Digital Health & AI Trends (May 2026)

Click the cover to download report highlights

Enterprise EHR Foundation

​KLAS Research confirms Epic dominance in the US hospital EHR for another year, with 57% of beds (Oracle has 20% and Meditech 13%). Boston Consulting Group highlights the opportunities in an AI-first care process where AI can bring expert reasoning into clinical decision-support workflows in real time and enterprise focus moves to re-engineering.

Healthcare Analytics and Intelligence

AVIA releases its buyers guide for virtual nursing highlighting ten core capabilities, as McKinsey assesses AI in nursing as not disruptive. And, as analysts predicted, pharma continues to be the big healthcare winner in AI investment, acquisitions, and partnerships. Notable are Isomorphic’s $2b+ Series B, Roche acquiring Path AI for digital pathology, and BMS implementing Claude from Anthropic everywhere.

Consumer Health and Technology

An Ipsos survey finds that consumer brands and healthcare orgs are converging on the same territory, with neither side having clear ownership yet. And several consumer segments made headlines this month. Labcorp, Hims, and Noom push deeper into at-home and consumer lab testing with new products and services, as several startups developing incontinence therapeutics attract over $100 million in VC dollars.

Stakeholders

Eli Lilly topped both the innovation and invention drug company R&D rankings, marking the first time one company topped both. Lilly also unveiled its next-generation obesity drug, with patients in the phase 3 trial losing nearly 30% of their body weight. In payer news, BCBS and Kaiser were the top ranked plans for member experience in multiple regions, while Research 2 Guidance looks at why EU payers trail US payer in AI adoption.